Loading...
Loading...
Among the 3 tracked institutional investors we monitor, GRCE (GRACE THERAPEUTICS INC) is held with a combined value of $2.36M across 811,256 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.48M. BlackRock, Inc. opened a new position in the most recent quarter. 2 funds increased their holdings.
Total Institutional Value
$2.36M
Total Shares Held
811,256
Institutional Holders
3
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.48M | 0.00% | +3.6% |
| 2 | CITADEL ADVISORS LLC | $793.91K | 0.00% | +254.2% |
| 3 | BlackRock, Inc. | $85.20K | 0.00% | New |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of GRCE with a position worth $1.48M, representing 0.00% of their portfolio. In total, 3 institutional investors hold GRCE with a combined value of $2.36M.
In the most recent quarter, 1 fund opened a new position in GRCE. Additionally, 2 increased their holdings.
Institutional investors hold $2.36M worth of GRCE stock across 3 positions. The largest institutional holder is VANGUARD GROUP INC with $1.48M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GRCE, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their GRCE positions.
| 2026-08-14 |
| 13.1% | 2026-08-07 |
SEC Schedule 13D (activist) and 13G (passive) filings for GRCE. Filed when an investor acquires 5%+ ownership.
Last Close
$1.97
2026-10-21
YTD
-46.2%
3% of 52-week range